Amixetrine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H27NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7UL287YTPJ, chemically known as pyrrolidine, n-(2-phenyl-2-isoamyloxy)ethyl- but generally known as amixetrine, which bears US NIH Compound Identifier 71911. Amixetrine most often comes in base and hydrochloride forms. European Medicines Agency schedules Amixetrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05464MIG. The term AMIXETRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). AMIXETRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amixetrine under HS 29339990 and SITC 51577. As of Q4 2014, AMIXETRINE remains the US FDA Preferred Term for this commodity. Amixetrine bears US NLM identifiers UMLS ID C0051695 and NCI Concept Code C73072. SMILES: O(C(CN1CCCC1)C1CCCCC1)CCC(C)C.